Researcher
Rob Lavigne
- Disciplines:Animal biology, Biological system engineering, Signal processing, Agricultural animal production
Affiliations
- Animal and Human Health Engineering (A2H) (Division)
Responsible
From1 Aug 2023 → Today - Animal and Human Health Engineering (A2H) (Division)
Member
From1 Aug 2020 → Today - Division Animal and Human Health Engineering (Division)
Member
From1 Aug 2015 → 31 Jul 2020 - Department of Biosystems (BIOSYST) (Department)
Member
From1 Aug 2006 → 30 Sep 2006
Projects
1 - 10 of 80
- Exploring the antibacterial and biotechnological potential of bacteriophagesFrom17 Jan 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- RePhactor - Phage-based biosynthetic gene cluster refactoring for the discovery and yield improvement of novel bioactive natural productsFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Bacteriophage research for biocontrol of Pseudomonas in cherryFrom10 Nov 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Machine learning for small peptide discovery and function annotationFrom1 Nov 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- An integrated approach to combat Staphylococcus aureus biofilms using designer enzymesFrom1 Oct 2023 → TodayFunding: IOF - technology validation in lab
- Direct deposition of therapeutic bacteriophages on orthopedic implant materials: development of an in vitro, preclinical proof-of-concept antibacterial strategy (PHAGE-DEPOSIT)From1 Oct 2023 → TodayFunding: BOF - projects
- SynBioS: Synergistic biocontrol technologies for disease and pest management in strawberryFrom1 Oct 2023 → TodayFunding: FWO Strategic Basic Research (SBO)
- Combining root-associated microorganisms and bacteriophages for enhanced biological control of pest insects.From19 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- KLEOPATRA: Development and implementation of an effective combination of phages and antibiotics as an improved therapy against Klebsiella pneumoniaeFrom1 Jun 2023 → TodayFunding: FWO Strategic Basic Research (SBO)
- SynPhage (Synthetic Phage)From16 Jan 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
Publications
21 - 30 of 348
- ECOPHAGE: Combating Antimicrobial Resistance Using Bacteriophages for Eco-Sustainable Agriculture and Food Systems(2023)
Authors: Rob Lavigne, Jeroen Wagemans
- Phage therapy for hidradenitis suppurativa: a unique challenge and possible opportunity for personalized treatment of a complex, inflammatory disease.(2023)
Authors: Lene Bens, Sabrina Green, Daan Jansen, Tom Hillary, Jelle Matthijnssens, João Guedelha Sabino, Séverine Vermeire, An Van Laethem, Jeroen Wagemans, Rob Lavigne
Pages: 1221 - 1229 - The phage-encoded protein PIT2 impacts Pseudomonas aeruginosa quorum sensing by direct interaction with LasR(2023)
Authors: Kaat Schroven, Hanne Hendrix, Jan Paeshuyse, Rob Lavigne
- Isolation and molecular characterization of the Salmonella Typhimurium orphan phage Arash(2023)
Authors: Jeroen Wagemans, Rob Lavigne
- Stability of magistral phage preparations before therapeutic application in patients with chronic rhinosinusitis, sepsis, pulmonary, and musculoskeletal infections(2023)
Authors: Saartje Uyttebroek, Willem-Jan Metsemakers, Yves Debaveye, Laura Van Gerven, Lieven Dupont, Melissa Depypere, Jeroen Wagemans, Rob Lavigne, Isabel Spriet, Jolien Onsea
- Engineering of bacteriophage-derived endolysins to treat streptococcal mammary gland infections(2023)
Authors: Rob Lavigne
- Isolation and Characterization of the Acadevirus Members BigMira and MidiMira Infecting a Highly Pathogenic Proteus mirabilis Strain(2023)
Authors: Lene Bens, Rob Lavigne, Jeroen Wagemans
- Mining phages as a source for novel anti-virulence approaches against Pseudomonas aeruginosa(2023)
Authors: Kaat Schroven, Rob Lavigne, Abram Aertsen
- Dismantling superbugs: engineering third-generation lysins as enzybiotics for burn wound infections(2023)
Authors: Vincent De Maesschalck, Rob Lavigne, Jan Paeshuyse
- In Vitro Persistence Level Reflects In Vivo Antibiotic Survival of Natural Pseudomonas aeruginosa Isolates in a Murine Lung Infection Model(2023)
Authors: Laure Verstraete, Rob Lavigne, Jan Michiels, Bram Van den Bergh
Patents
1 - 10 of 10
- Antimicrobial agents (Inventor)
- Antimicrobial agents (Inventor)
- Novel dnase (Inventor)
- New endolysin obpgplys (Inventor)
- Polynucleotide shuffling method (Inventor)
- Novel dnase (Inventor)
- Antimicrobial agents (Inventor)
- Polynucleotide shuffling method (Inventor)
- Antimicrobial agents (Inventor)
- Antimicrobial agents (Inventor)